Vitro Biopharma
Pre-clinicalVitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.
Founded
2006
Focus
Cell TherapyRegenerative Medicine
About
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.
Funding History
2Total raised: $8.3M
Series A$6.5MUndisclosedMay 15, 2019
Seed$1.8MUndisclosedSep 15, 2017
Company Info
TypePrivate
Founded2006
LocationGolden, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile